Concepedia

Ulrich Aigner

UA

1

Publications

286

Citations

1

H-Index

2017

Active since

Affiliations

Breakthrough T1D(Current)

Ulrich Aigner is an author at Breakthrough T1D specializing in metabolic syndrome, pharmacotherapy, and diabetes.

Top concepts

DiabetesMedicineHealth PolicyPublic HealthPharmacotherapyMetabolic SyndromeCardiovascular Disease

Publications per year

2017–2017

1

Publications

1

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9

Rows per page

1–1 of 1